ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.59
+0.47 (5.15%)
Nov 22, 2024, 4:00 PM EST - Market closed
ORIC Pharmaceuticals Employees
ORIC Pharmaceuticals had 100 employees as of December 31, 2023. The number of employees increased by 14 or 16.28% compared to the previous year.
Employees
100
Change (1Y)
14
Growth (1Y)
16.28%
Revenue / Employee
n/a
Profits / Employee
-$1,198,700
Market Cap
676.74M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100 | 14 | 16.28% |
Dec 31, 2022 | 86 | 8 | 10.26% |
Dec 31, 2021 | 78 | 17 | 27.87% |
Dec 31, 2020 | 61 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Standard BioTools | 539 |
Phathom Pharmaceuticals | 452 |
OrthoPediatrics | 247 |
EyePoint Pharmaceuticals | 121 |
AnaptysBio | 117 |
Stoke Therapeutics | 110 |
Dianthus Therapeutics | 53 |
Tourmaline Bio | 44 |
ORIC News
- 18 days ago - ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 7 weeks ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates - GlobeNewsWire
- 3 months ago - ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs - GlobeNewsWire